In the latest WHO classification of tumors of the CNS, GBM contains only IDH-wildtype tumors, and IDH-mutant GBM was no longer defined as GBM but defined as astrocytoma, IDH mutation of the CNS (WHO 4). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).